Tag Archives: Kinectrics

CNA2020

New partnerships mean more medical isotope production

Image of Westinghouse and Nordion executives signing a letter of intent.
Westinghouse and Nordion signed a letter of intent to develop innovative isotope production technology that will allow cobalt-60 to be produced in pressurized water reactors.

According to the Canadian Nuclear Isotope Council, the global isotope market was estimated to be US$9.6 billion. It is projected to grow to more than US$17.1 billion by 2023. Canada’s position in that market recently got stronger with two new partnership agreements.

Framatome and Kinectrics Launch Joint Venture to Produce Medical Isotopes for Lifesaving Cancer Treatment

At CNA2020 on Feb. 28, Framatome and Kinectrics announced the launch of Isogen. The joint venture will provide and support isotope production systems for Bruce Power’s nuclear reactors to begin the production of lutetium-177.

Lutetium-177 is used as a gamma emitter for imaging. It is also a beta emitter used for targeted radiotherapy for the treatment of a growing number of cancers, including prostate cancer, neuroendocrine tumours and bone metastases.

“We are proud to have established a new Ontario-based company, Isogen, with our partner, Framatome,” said David Harris, Kinectrics president and CEO. “Together, we will work with Bruce Power to produce life-saving medical isotopes, specifically lutetium-177, which will help to advance the global fight against cancer.”

“Partnering with Kinectrics to launch Isogen marks our commitment to advance isotope development as we continue to work with the team at Bruce Power in the fight against cancer,” said Bernard Fontana, CEO at Framatome. “Together, we are working with Bruce Power to maximize existing infrastructure, already known for producing reliable, low-carbon electricity, and making important, life-saving medical treatments available to patients around the world.”

The partnership will leverage the scale, redundancy and longevity of the eight-unit facility to anchor a new, global supply of isotopes. Following regulatory and other approvals, the plan is to begin isotope production in 2022. The goal is to allow scaling based on demands for lutetium-177 and other isotopes.

“As home to Ontario’s largest private-sector infrastructure project, we are not only extending our assets to provide low-cost, clean electricity for our families and business but are also ensuring that we are playing a leadership role in providing the global health community with access to isotopes that are critical to a modern health-care system and in the fight against cancer,” said Michael Rencheck, president and CEO of Bruce Power.

Westinghouse Partners with Nordion to Increase Future Supply of Life-Saving Cobalt-60

Two days before the Isogen announcement, Westinghouse Electric Company and Nordion (Canada) Inc. announced they signed a letter of intent to develop innovative isotope production technology that will allow cobalt-60 to be produced in pressurized water reactors (PWRs).

Cobalt-60 is the most common radioisotope used in radiation therapy. Hospitals also use cobalt-60 to sterilize medical equipment, such as gowns, gloves, masks, syringes and implants.

“Westinghouse, a leader in nuclear technology throughout the world, brings a strong set of operational experience, engineering skills and a robust safety culture to this collaboration. We look forward to contributing to the health and well-being of people around the world,” said Patrick Fragman, president and CEO of Westinghouse.

“This partnership will substantially expand future supply options for life-saving cobalt-60,” said Kevin Brooks, president of Nordion, a leading supplier of cobalt-60 globally. “Cobalt-60 is critical to our mission of Safeguarding Global Health, and we continue to invest heavily in maintaining a reliable, long-term supply.”

According to the World Nuclear Association, almost all the world’s supply of the radioisotope is produced in Candu reactors, mostly in Canada.

Expanding production to PWRs — of which there are nearly 100 in North America alone — will strengthen the diversity of the global supply chain.

CNA2020

NUCLEAR IN SCIENCE AND MEDICINE

In the century or so since the start of nuclear science, we’ve made many useful discoveries. Nuclear medicine covers diagnosing diseases, treating patients with cancer and sterilizing gowns, gloves, masks, syringes and implants. What are the next exciting frontiers? Find out during a panel presentation on February 28 from 10:30 to 11:30 at CNA2020.

As the Technical and Business Director for Medical Isotopes at Kinectrics, Travis Besanger is responsible for building a strong value chain for Kinectrics’s products and for establishing a state-of-the-art isotope processing centre at the company’s Teeswater, Ontario, location. Before joining Kinectrics in 2019, he had 13 years of experience in the radiopharmaceutical industry. Most of that was at the Centre for Probe Development and Commercialization, where he led commercialization of radiopharmaceuticals and medical isotope products.

Image of Thomas R. Burnett is Vice-President and General Manager of BWXT Isotope Technology Group (ITG) Canada. He is responsible for all aspects in the establishment and direction of the BWXT ITG Canada operation. Before joining BWXT in 2017, Burnett had varying levels of responsibility in the nuclear medicine industry related to marketing. He has worked in sales, general management and consulting at Nordion, Thermo Fisher Scientific, Ernst & Young and Merck Frosst.

Image of Karen MossmanKaren Mossman is the Associate Vice-President of Research at McMaster University. Mossman joined McMaster in 2001 with a research focus on understanding the interactions between viruses and their hosts, both in normal healthy cells and in cancer cells. The Department of Pathology and Molecular Medicine Professor’s goal is to develop novel therapy approaches for emerging viral infections and cancer. She also serves as Chair of the Board of the McMaster Innovation Park.

Find the complete CNA2020 schedule at https://cna.ca/cna2020/program/.

To register for the conference, visit https://cna.ca/cna2020/registration/.

CNA2020 Uncategorized

CNA Sponsorship Spotlight: Kinectrics

Students are the future of any industry. That’s one of the reasons why the Canadian Nuclear Association is pleased to have Kinectrics as the Gold-Level Sponsor of the Starting Your Nuclear Career student event at CNA2020.

Kinectrics’ origins can be traced back to 1912 as the technical and research division of Ontario Hydro, which was the largest electrical utility in North America. Ontario Hydro covered generation from nuclear, fossil, hydroelectric and renewable sources, as well as transmission and distribution. In the 1990s, the province broke-up and re-organized Ontario Hydro into multiple companies.

Kinectrics is a leader in engineering, testing, inspection, certification and consulting. Based in Toronto, it has more than 25 laboratory and testing facilities. Trusted by clients worldwide, its expertise is backed by a diverse fleet of field inspection equipment and an award-winning team of over 1,000 engineers and technical experts.

In December, Kinectrics opened a new 40,000-square-foot facility in Teeswater on nine acres of industrial property that will provide laundry services to Bruce Power. In 2017, Kinectrics opened the cornerstone of its expansion, a 37,000-square-foot facility at the Bruce Energy Centre, in Kincardine. With these two facilities, Kinectrics has invested more than $50 million in Bruce County initiatives over the past few years.

In November, partnership agreements between Ontario and international firms established the province as a stable global supplier of the life-saving medical isotope Lutetium-177. The agreements involved Bruce Power, Kinectrics, Framatome and ITM, a biotechnology and radiopharmaceutical group of companies based in Munich with a global network of production facilities. The two partnership agreements cover research, development, production, processing and export.

At CNA2020, the Kinectrics-sponsored Starting Your Nuclear Career event is set for Wednesday, February 26 from 15:00 to 17:00. This career information seminar is open to student delegates. It will feature recruitment professionals and a resume review from some of Canada’s leading nuclear companies.

Find the complete conference schedule at https://cna.ca/cna2020/program/.

To register, please visit https://cna.ca/cna2020/registration/.